Last reviewed · How we verify

NCT06172569

Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Study

Recruiting now Last updated 15 December 2023
What this trial tests

trial testing Spartan Stem, World Acetabular Cup and World Liner in Hip Replacement in 200 participants. Currently enrolling.

Timeline
8 December 2023
Primary endpoint
1 April 2028
1 April 2028

Quick facts

Lead sponsorSignature Orthopaedics
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date8 December 2023
Primary completion1 April 2028
Estimated completion1 April 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Signature Orthopaedics

Who can join

Adults 18 to 75, any sex, with Hip Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to monitor the performance of the Signature Orthopaedics Spartan Stem, World Acetabular Cup and World Liner as a post-market vigilance and continuous improvement efforts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Signature Orthopaedics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06172569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing